₹15452
₹18916
(18% Off)
Inclusive of all taxes
Qty
Buying in bulk?
In Stock
Guaranteed Service
Free Home Delivery
above ₹199
Check Delivery
Enter pincode for exact delivery dates / charges and to know if express delivery is available
Emerging Drugs and Targets for Alzheimer's Disease: Volume 1: Beta-Amyloid, Tau Protein and Glucose Metabolism (RSC Drug Discovery)
by Ana Martinez, David E Thurston (Author),
Royal Society of Chemistry (Publisher)
Product Specifications
Book Description
Alzheimer's disease is the most prevalent neurodegenerative disorder in the
elderly. A recent study from the Bloomberg School of Public Health recently
estimated that over 26 million people were living with the disease in 2006 and
that the global prevalence of the disease will grow to 106 million by 2050. By
that time, 43 per cent of those living with the disease will need high-level
care, equivalent to that of a nursing home. However, even if modest advances in
preventing or delaying the disease's progression were made, it could have a huge
impact on global public health. According to this study, interventions that
could delay the onset
Book Specifications
ISBN-13 9781849730631
Language English
Binding Hard Bound
Publisher Royal Society of Chemistry
Publishing Date 2010-05-07
Product Edition 1st Edition.
Total Pages 342